Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration

Annals of Surgical Oncology

Volumn 8, Issue 2, 2001, Pages 123-132

  Breslin, T M ^a   Hess, K R ^a   Harbison, D B ^a   Jean, M E ^a   Cleary, K R ^a   Dackiw, A P ^a   Wolff, R A ^a   Abbruzzese, J L ^a   Janjan, N A ^a   Crane, C H ^a   Vauthey, J N ^a   Lee, J E ^a   Pisters, P W T ^a   Evans, D B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemoradiation; Pancreatic cancer; Pancreaticoduodenectomy

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; GEMCITABINE; PACLITAXEL;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PREOPERATIVE CARE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; PANCREATECTOMY; PANCREATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035093234     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.2.123     Document Type: Article

References (27)

1. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer
2. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection
3. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience
4. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC Gastrointestinal Tract Cooperative Group
5. ESPAC-1 interim results: A European, randomized study to assess the roles of adjuvant chemotherapy (5FU+folinic acid) and adjuvant chemoradiation (40 Gy+5FU) in resectable pancreatic cancer
6. Cancer of the pancreas
7. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head
8. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ±5-fluorouracil
9. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group
10. Adjuvant therapy of resected adenocarcinoma of the pancreas
11. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas
12. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas
13. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma
14. Letter to the editor
15. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms
16. Comparative toxicities of preoperative paclitaxel vs. 5-fluorouracil based rapid fractionation chemoradiation for resectable pancreatic adenocarcinoma
17. Phase I trial of gemcitabine combined with radiation for treatment of locally advanced pancreatic adenocarcinoma
18. Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer
19. Major vascular resection as part of pancreaticoduodenectomy for cancer: Radiologic, intraoperative, and pathologic analysis
20. Intraoperative radiation therapy following pancreaticoduodenectomy
21. The need for standardized pathologic staging of pancreaticoduodenectomy specimens
22. Nonparametric estimation from incomplete observations
23. Prognostic indicators for survival after resection of pancreatic adenocarcinoma
24. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
25. Six hundred and fifty consecutive pancreaticoduodenectomies in the 1990s
26. Standard versus extended lymphadenectomy with pancreaticoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas. A multicenter, prospective, randomized study
27. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy